MDXG vs ITIC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MDXG · MiMedx$3.31 ▲ 0.91%
ITIC · Investors Title$256.37 ▼ 1.89%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MDXG -57.1%
- ITIC -3.9%
Head to head
| Metric | MDXG | ITIC |
|---|---|---|
| Price | $3.31 | $256.37 |
| Change today | ▲ 0.91% | ▼ 1.89% |
| Market cap | $483.01M | $484.03M |
| Return, 3 months | -22.5% | -10.2% |
| Return, year to date | -51.1% | +3.3% |
| Return, 1 year | -55.5% | -4.0% |
| P/E (TTM) | -25.5 | 12.9 |
| P/B | 2.3 | 1.6 |
| P/E percentile vs own 5y | 14th | 44th |
| Dividend yield | – | 0.72% |
| Revenue growth (YoY, latest qtr) | -45.2% | +17.7% |
| Net profit growth (YoY) | -151.8% | +19.2% |
| Gross margin | 77.3% | – |
| Operating margin | -8.3% | – |
| Net margin | -6.3% | 13.8% |
| Return on equity | -8.5% | 14.6% |
| Analyst target vs. price | +111.5% | – |
| Analyst buy share | 100% | – |
| RSI (14) | 26 | 30 |
| 30-day volatility | 66.6% | 25.7% |
| Max drawdown, 1 year | -61.2% | -24.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ITIC is the largest of the group by market value.
- ITIC has returned the most over the past year.
- MDXG carries the lowest trailing P/E.
- ITIC is growing revenue fastest.
- ITIC keeps the most profit per dollar of sales.
- ITIC has been the calmest stock over the last 30 days.